I now have comprehensive content from multiple authoritative sources. Here is the full, synthesized answer:
Treatment of Diabetic Ketoacidosis (DKA)
Management of DKA should preferably be conducted in an ICU. The three therapeutic priorities are fluid replacement, insulin administration, and potassium repletion. Bicarbonate, phosphate, and magnesium are not routinely given but may be appropriate in selected patients.
1. Initial Assessment
Before treatment, obtain:
- Serum glucose, electrolytes (BMP), BUN/creatinine, ketones
- Arterial or venous blood gas
- CBC with differential, urinalysis
- ECG (to evaluate electrolyte effects and rule out silent MI as precipitant)
- Chest X-ray if infection is suspected
- Search for and treat the precipitating cause (infection, medication non-compliance, new-onset DM)
2. IV Fluid Resuscitation
Fluid deficits in DKA average 7-9% of body weight (roughly 3-5 L in adults). Fluid alone can drop plasma glucose ~18% by improving renal perfusion and insulin delivery to tissues.
Step 1 - Restore circulating volume:
- 0.9% normal saline (NS): 1 L bolus, then 500-1000 mL/h (if cardiac and renal function are normal)
Step 2 - Replenish total-body water deficit:
- Switch to 0.45% NS (or continue 0.9% NS if hyponatremic): 150-500 mL/h
- Adjust based on BP and urine output; aim for no faster than 3 mOsm/kg/h correction
- Target positive fluid balance over 12-24 hours
When to switch fluids:
- Add dextrose (D5W) to the IV fluid when blood glucose falls to <250 mg/dL (or is predicted to fall below 200 mg/dL within 1 hour) - this prevents hypoglycemia while insulin continues to clear ketones
- The two-bag approach (one bag NS, one bag D5W run in parallel with separate rates) allows independent titration of glucose and fluid, and has been shown to shorten treatment duration
Pediatric note: Give an initial 20 mL/kg NS bolus in the first hour if in shock; repeat if needed. Replace remaining fluid deficit evenly over 24-48 hours to minimize the risk of cerebral edema. Avoid overly rapid correction, especially if calculated osmolarity >340 mOsm/L.
Recent evidence (2024): A meta-analysis (PMID
38925619) found that balanced electrolyte solutions (e.g., PlasmaLyte, Lactated Ringer's) result in faster resolution of DKA than 0.9% NS, likely by avoiding hyperchloremic acidosis. This is an evolving area - consider balanced crystalloids especially if large volumes are needed.
3. Potassium Replacement
Total-body potassium is always depleted in DKA, even when serum K+ appears normal or high (acidosis shifts K+ extracellularly). With insulin and correction of acidosis, K+ shifts back intracellularly and serum levels can fall precipitously.
| Serum K+ | Action |
|---|
| <3.3 mEq/L | Do NOT give insulin yet. Correct K+ first to ≥3.5 mEq/L. Administer 20-40 mEq/h KCl. |
| 3.3-5.5 mEq/L | Add 20-40 mEq KCl per liter of IV fluid. Continue insulin. |
| >5.5 mEq/L | Hold potassium replacement; monitor closely. Do not give insulin until K+ <5.5. |
- Standard rate: 10-20 mEq/h added to IV fluids, targeting K+ 4-5 mEq/L
- In pediatric patients: add 30 mEq/L (half as KCl, half as KPhos) if K+ 3.5-5.5 mEq/L and child is urinating
4. Insulin Therapy
Critical prerequisite: Do not start insulin until K+ ≥ 3.3 mEq/L.
Standard IV regimen (adults):
- Bolus: 0.1 units/kg regular insulin IV
- Infusion: 0.1 units/kg/h regular insulin IV (standard preparation: 100 units regular insulin in 100 mL 0.9% NS = 10 mL/h delivers 10 units/h)
Target glucose fall: 50-75 mg/dL/h. Do not correct faster than 100 mg/dL/h (risk of osmotic encephalopathy).
When glucose reaches <250 mg/dL:
- Add dextrose to IV fluids (see above)
- Reduce insulin infusion to 0.05 units/kg/h (do NOT stop insulin - ketosis may still be present)
- Continue insulin at low rate (1-2 units/h) until:
- HCO3- >15 mEq/L
- Anion gap is closed
- Clinical improvement
Subcutaneous insulin as an alternative:
- Mild-to-moderate DKA may be managed with subcutaneous insulin protocols in non-ICU settings
- A 2024 meta-analysis (PMID 39090718) found no significant difference in outcomes between subcutaneous insulin and continuous IV insulin infusion for adults with DKA, supporting the use of SC insulin in appropriate patients
Transition to subcutaneous insulin:
- Administer subcutaneous basal insulin 2 hours before stopping the insulin infusion to prevent rebound hyperglycemia/ketosis
5. Bicarbonate
Not routinely recommended. Insulin and fluids correct acidosis adequately in most cases.
Consider bicarbonate only if:
- Shock or coma
- pH <6.9
- HCO3- <5 mEq/L
- Cardiac or respiratory dysfunction
- Severe hyperkalemia with ECG changes
Dose: 50-100 mEq NaHCO3 in 1 L of 0.45% NS over 30-60 minutes; follow arterial pH. Add 10 mEq KCl to avoid hypokalemia.
6. Phosphate and Magnesium
- Phosphate: Not routinely replaced. May give as KPhos in IV fluids if patient is not eating.
- Magnesium: May give 1-2 g MgSO4 IV. Serum levels may not reflect body stores. Give 10-20 mEq magnesium sulfate IV if ventricular arrhythmias are present.
7. Monitoring
| Parameter | Frequency |
|---|
| Bedside glucose | Every 1 hour |
| Serum electrolytes (K+, Cl-, HCO3-, Na+) | Every 2-4 hours |
| Blood gas | As needed (especially if severe acidosis/hypoxia) |
| Vital signs and urine output | Continuously |
| ECG | Continuous cardiac monitoring (especially in children) |
Watch for: Rising serum sodium as hyperglycemia corrects (expected). If Na+ does not rise, the patient may be being overhydrated with free water.
In children: Continuous cardiac monitoring is mandatory as QTc prolongation occurs frequently during DKA and can cause torsades de pointes. Avoid QT-prolonging drugs (e.g., ondansetron).
8. Resolution Criteria (to stop insulin infusion)
- Blood glucose <200 mg/dL
- Serum HCO3- ≥15 mEq/L
- Anion gap closed (AG ≤12 mEq/L)
- Patient able to eat and drink
Summary at a Glance
| Intervention | Key Point |
|---|
| Fluids | 0.9% NS bolus → 0.45% NS for deficit; add D5 when glucose <250 |
| Potassium | Replace before insulin if K+ <3.3; add 20-40 mEq/L throughout |
| Insulin | 0.1 units/kg bolus + 0.1 units/kg/h infusion; reduce (don't stop) when glucose <250 |
| Bicarbonate | Only if pH <6.9, shock, or coma |
| Phosphate/Mg | Not routine; treat if symptomatic or arrhythmia |
| Monitoring | Glucose hourly, electrolytes q2-4h |
Sources: The Washington Manual of Medical Therapeutics, p. 890-891; Rosen's Emergency Medicine, p. 2544; Tintinalli's Emergency Medicine (Pediatric DKA)